Skip to main content

Table 1 Detailed imaging parameters of the magnetic resonance imaging instruments used in the current investigation

From: Quantitative assessment of washout in hepatocellular carcinoma using MRI

Sonata® Avanto® Trio® Skyra®
T2wa tra T2wa tra T2wa tra T2wa tra
T1w in/opposed phase b tra T1w in/opposed phase b tra T1w in/opposed phase b tra T1w in/opposed phase b tra
Diffusion-weighted imaging tra Diffusion-weighted imaging tra Diffusion-weighted imaging tra Diffusion-weighted imaging tra
4x T1w fs (native, arterial, portal venous, equilibrium) c 4x T1w fs (native, arterial, portal venous, equilibrium) d 4x T1w fs (native, arterial, portal venous, equilibrium) d 4x T1w fs (native, arterial, portal venous, equilibrium) d
T1w b tra/cor (delayed) T1w b tra (delayed) T1w b tra (delayed) T1w b tra (delayed)
  1. tra transversal, cor coronal
  2. a T2-weighted half-Fourier acquisition single-shot turbo spin-echo sequence (HASTE)
  3. b T1-weighted fat-suppressed fast low-angle shot gradient echo sequence (FLASH®)
  4. c T1-weighted fat-suppressed multi-phase contrast-enhanced series (FL 3d)
  5. d T1-weighted fat-suppressed multi-phase contrast-enhanced series (VIBE®)